Geneva Capital Management LLC Sells 32,612 Shares of Ryan Specialty Holdings Inc. $RYAN

Geneva Capital Management LLC trimmed its holdings in Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 6.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 510,803 shares of the company’s stock after selling 32,612 shares during the quarter. Geneva Capital Management LLC’s holdings in Ryan Specialty were worth $18,900,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. Hantz Financial Services Inc. raised its holdings in shares of Ryan Specialty by 4.8% in the 3rd quarter. Hantz Financial Services Inc. now owns 13,617 shares of the company’s stock worth $504,000 after purchasing an additional 618 shares in the last quarter. Royce & Associates LP boosted its holdings in Ryan Specialty by 1.5% during the third quarter. Royce & Associates LP now owns 197,857 shares of the company’s stock worth $7,321,000 after buying an additional 2,923 shares in the last quarter. Diversified Trust Co boosted its holdings in Ryan Specialty by 6.6% during the third quarter. Diversified Trust Co now owns 32,470 shares of the company’s stock worth $1,201,000 after buying an additional 2,014 shares in the last quarter. Fifth Third Bancorp boosted its holdings in Ryan Specialty by 8.8% during the third quarter. Fifth Third Bancorp now owns 28,944 shares of the company’s stock worth $1,071,000 after buying an additional 2,341 shares in the last quarter. Finally, Maryland State Retirement & Pension System acquired a new position in Ryan Specialty in the third quarter worth approximately $238,000. Institutional investors own 84.82% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on RYAN. JPMorgan Chase & Co. upped their price target on Ryan Specialty from $39.00 to $45.00 and gave the company an “underweight” rating in a report on Monday, August 3rd. The Goldman Sachs Group raised their price objective on Ryan Specialty from $40.00 to $45.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Royal Bank Of Canada reduced their price objective on Ryan Specialty from $55.00 to $52.00 and set an “outperform” rating for the company in a research note on Friday, October 30th. Mizuho lifted their target price on Ryan Specialty from $40.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday. Finally, Piper Sandler decreased their target price on Ryan Specialty from $48.00 to $40.00 and set a “neutral” rating on the stock in a report on Tuesday, October 6th. Eight analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Ryan Specialty presently has an average rating of “Hold” and an average target price of $52.62.

Read Our Latest Stock Analysis on Ryan Specialty

Insider Buying and Selling

In related news, CEO Benjamin Wuller sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $47.31, for a total value of $2,365,500.00. Following the completion of the transaction, the chief executive officer owned 94,095 shares of the company’s stock, valued at approximately $4,451,634.45. This trade represents a 34.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 52.03% of the company’s stock.

Ryan Specialty Price Performance

RYAN stock opened at $46.80 on Monday. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 4.03. Ryan Specialty Holdings Inc. has a one year low of $29.28 and a one year high of $58.91. The firm has a market capitalization of $11.77 billion, a PE ratio of 57.78, a P/E/G ratio of 0.99 and a beta of 0.54. The firm has a 50-day moving average of $41.17 and a two-hundred day moving average of $39.00.

Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its earnings results on Thursday, October 29th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.49 by $0.02. Ryan Specialty had a net margin of 8.25% and a return on equity of 47.77%. The company had revenue of $789.96 million during the quarter, compared to analysts’ expectations of $792.99 million. During the same period last year, the company posted $0.47 earnings per share. On average, analysts forecast that Ryan Specialty Holdings Inc. will post 2.18 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 24th. Investors of record on Tuesday, November 10th will be given a $0.13 dividend. This represents a $0.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Tuesday, November 10th. Ryan Specialty’s dividend payout ratio is 64.20%.

About Ryan Specialty

(Free Report)

Ryan Specialty is a specialty insurance organization that provides distribution, underwriting and related services to insurance brokers, agents and carriers. Its business includes wholesale brokerage, which helps insurance professionals place coverage for risks that may be difficult to insure in the standard market, and underwriting management services for specialty insurance products. The company works across a range of property and casualty insurance lines, including professional liability, transportation, property, casualty and other specialty risks.

Further Reading

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.